Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Timolol-LA reported as effective as timolol maleate in reducing ocular hypertension

May 15, 2003

Dietary omega n-3 LCPUFAs reduce the risk for AMD

May 15, 2003

Genaera reports early findings for squalamine in AMD

May 14, 2003

Fab fragment targeting alpha5beta1 integrin inhibits CNV in monkeys

May 13, 2003

Antiviral and antiinflammatory effects for N-chlorotaurine in adenoviral keratoconjunctivitis

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Timolol 0.1% gel as effective as latanoprost 0.005% gel in early glaucoma

May 9, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

INS-37217 reported effective as adjunct in retinal reattachment surgery

May 9, 2003

Improved retinal thickness found with midostaurin in diabetic macular edema

May 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...